RE:News misinterpreted?There is no misinterpretation. 1067 has much lower concentration compared to products in the market and slow effect is not something unexpected. We will hear soon and data will speak itself whether it is good enough or not.
They never showed head to head preclinical skin patch comparision including the marketed products. And I do not see any good reasons not to do so.
Just be aware, this is still not risk free even though the first refusal agreement was a good sign.